Novo spokeswoman Ambre James-Brown described Hims mass compounding as illegal
So, if you have plateaued in your weight loss on the 2.4 mg dose and it is well tolerated, you may have the option to go to the 7.2 mg dose and see if additional weight loss is experienced
Fortunately, there are several strategies to manage and reduce these gastrointestinal side effects
GLP-1 receptor agonists work by supporting natural pathways involved in appetite regulation, digestion, and metabolic processes
Book Your Consultation Today Ready to get started
Specific Risks of Semaglutide While generally considered safer due to its non-surgical nature, Semaglutide has specific medical considerations: Gastrointestinal Distress: About 60% of users experience mild-to-moderate GI issues, typically during the dose-escalation phase